Item 1.01 Entry into a Material Definitive Agreement.
On
The foregoing description of the Option Agreement is only a summary and is qualified in its entirety by reference to the full text of the Option Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference in this Item 1.01.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 10.1* Option Agreement, datedOctober 8, 2022 , by and between ExacisBiotherapeutics, Inc. andBrooklyn ImmunoTherapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar
attachments to this exhibit have been omitted because they do not contain
information material to an investment or voting decision and such information is
not otherwise disclosed in such exhibit. The Company will supplementally provide
a copy of any omitted schedule or similar attachment to the
--------------------------------------------------------------------------------
© Edgar Online, source